7WPF
SARS-CoV-2 Omicron Variant S Trimer complexed with three JMB2002 Fab
7WPF の概要
エントリーDOI | 10.2210/pdb7wpf/pdb |
EMDBエントリー | 32685 |
分子名称 | Spike glycoprotein, JMB2002 Fab heavy chain, JMB2002 Fab light chain, ... (6 entities in total) |
機能のキーワード | antibody, viral protein |
由来する生物種 | Severe acute respiratory syndrome coronavirus 2 詳細 |
タンパク質・核酸の鎖数 | 12 |
化学式量合計 | 599914.87 |
構造登録者 | |
主引用文献 | Yin, W.,Xu, Y.,Xu, P.,Cao, X.,Wu, C.,Gu, C.,He, X.,Wang, X.,Huang, S.,Yuan, Q.,Wu, K.,Hu, W.,Huang, Z.,Liu, J.,Wang, Z.,Jia, F.,Xia, K.,Liu, P.,Wang, X.,Song, B.,Zheng, J.,Jiang, H.,Cheng, X.,Jiang, Y.,Deng, S.J.,Xu, H.E. Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody. Science, 375:1048-1053, 2022 Cited by PubMed Abstract: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant has become the dominant infective strain. We report the structures of the Omicron spike trimer on its own and in complex with angiotensin-converting enzyme 2 (ACE2) or an anti-Omicron antibody. Most Omicron mutations are located on the surface of the spike protein and change binding epitopes to many current antibodies. In the ACE2-binding site, compensating mutations strengthen receptor binding domain (RBD) binding to ACE2. Both the RBD and the apo form of the Omicron spike trimer are thermodynamically unstable. An unusual RBD-RBD interaction in the ACE2-spike complex supports the open conformation and further reinforces ACE2 binding to the spike trimer. A broad-spectrum therapeutic antibody, JMB2002, which has completed a phase 1 clinical trial, maintains neutralizing activity against Omicron. JMB2002 binds to RBD differently from other characterized antibodies and inhibits ACE2 binding. PubMed: 35133176DOI: 10.1126/science.abn8863 主引用文献が同じPDBエントリー |
実験手法 | ELECTRON MICROSCOPY (2.92 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
